Valuation : EDAP TMS S.A.

Market Cap 188M 162M 154M 139M 261M 18B 263M 1.82B 702M 9.15B 708M 692M 28.93B P/E 2026 *
-3.45x
P/E 2027 * -5.34x
Enterprise Value 188M 162M 154M 139M 261M 18B 263M 1.82B 702M 9.15B 708M 692M 28.93B EV / Sales 2026 *
3.62x
EV / Sales 2027 * 2.7x
Free-Float
32.85%
Yield 2026 *
-
Yield 2027 * -
1 day-1.44%
1 week-1.20%
Current month-3.98%
1 month-31.78%
3 months-12.77%
6 months-0.97%
Current year+24.62%
1 week 4.02
Extreme 4.015
4.3
1 month 4.01
Extreme 4.01
4.93
Current year 3.1
Extreme 3.1
6.4
1 year 1.75
Extreme 1.75
6.4
3 years 1.21
Extreme 1.21
8.5
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2023
Director of Finance/CFO 55 31/12/2023
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 64 31/07/2023
Chairman 64 31/08/2024
Director/Board Member 62 07/07/2024
Date Insider Type Main position Quantity % Market Cap. Importance
14/08/26 Buy

Chief Financial Officer

5,000 0.0133%
14/08/26 Buy

Director

10,000 0.0267%
14/08/26 Buy

Chairman

50,000 0.1334%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-1.20%+57.09%-35.94% 188M
+1.10%-0.65%+24.10%+18.43% 225B
-0.19%-3.62%+2.55%-20.00% 141B
+2.41%+0.67%-19.02%+22.09% 130B
-0.28%-10.08%-58.81%-21.22% 62.29B
-2.77%-6.15%+8.15%+12.69% 48.63B
-0.49%-1.97%-20.35%-15.53% 49.39B
+2.66%-2.61%+15.94%+29.91% 41.42B
+1.67%-0.25%+35.01%+55.09% 40.12B
-0.60%-4.41%-20.52%+44.06% 31.23B
Average +0.21%-3.20%+2.41%+8.96% 76.99B
Weighted average by Cap. +0.67%-2.50%+0.62%+9.83%

Financials

2026 *2027 *
Net sales 52M 44.84M 42.43M 38.46M 72.11M 4.97B 72.54M 504M 194M 2.52B 195M 191M 7.98B 69.73M 60.13M 56.91M 51.58M 96.71M 6.66B 97.28M 675M 260M 3.39B 262M 256M 10.71B
Net income -47.66M -41.1M -38.9M -35.26M -66.1M -4.55B -66.49M -462M -177M -2.31B -179M -175M -7.32B -31.59M -27.24M -25.78M -23.37M -43.81M -3.02B -44.07M -306M -118M -1.53B -119M -116M -4.85B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
11/09/26 US$4.100 -1.44% 66,302
10/09/26 US$4.160 -0.95% 112,865
09/09/26 US$4.200 -0.24% 87,400
08/09/26 US$4.210 +1.45% 109,693
04/09/26 US$4.150 -0.48% 103,139
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.100USD
Average target price
8.600USD
Spread / Average Target
+109.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!